Loading…

Patients’ perceptions on active surveillance for the treatment of small renal masses

•Several factors influence patients’ perceptions of active surveillance.•The physician's recommendation was reported as the most influencing factor.•The development of more patient-oriented information tools is needed.•Focus group discussion can be conducted virtually without any major outcome&...

Full description

Saved in:
Bibliographic Details
Published in:Urologic oncology 2022-11, Vol.40 (11), p.493.e17-493.e23
Main Authors: Charbonneau, Geneviève, Hudon, Catherine, Lavallée, Luke T., Kassouf, Wassim, Gaboury, Isabelle, Toren, Paul, Couture, Félix, Foley, Véronique, Tétu, Amélie, Richard, Patrick O.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c290t-8766eb640247126a0be51eed18de9bb1f75d82b171963141da7f84260e659083
container_end_page 493.e23
container_issue 11
container_start_page 493.e17
container_title Urologic oncology
container_volume 40
creator Charbonneau, Geneviève
Hudon, Catherine
Lavallée, Luke T.
Kassouf, Wassim
Gaboury, Isabelle
Toren, Paul
Couture, Félix
Foley, Véronique
Tétu, Amélie
Richard, Patrick O.
description •Several factors influence patients’ perceptions of active surveillance.•The physician's recommendation was reported as the most influencing factor.•The development of more patient-oriented information tools is needed.•Focus group discussion can be conducted virtually without any major outcome's impact. Most patients diagnosed with a small renal mass (SRM) are treated with definitive treatments such as surgery or thermal ablation. Given that some SRMs are benign or have low metastatic potential, active surveillance seeks to reduce the overtreatment and the potential complications. Active surveillance is an alternative that is being increasingly considered. Active surveillance has already been shown to be effective, but there is a current knowledge gap regarding patients’ perceptions of active surveillance and factors influencing their decision. To describe patients’ perceptions of active surveillance of SRMs and to identify factors influencing those perceptions. This multicenter descriptive qualitative study recruited patients diagnosed with a renal mass from three institutions, using purposeful sampling. Data were collected using focus group discussions, which were recorded and transcribed. A mixed thematic analysis was performed. Six focus group discussions were conducted with a total of 24 participants. Participants perceived active surveillance as an option to avoid definitive treatments and their potential risks. Active surveillance was, however, perceived to be a temporary solution that would affect their chance of survival and their quality of life. Seven factors were documented as influencing patients’ perceptions of active surveillance, the most important being their physician's recommendation. Perceptions of patients with SRMs toward active surveillance varies among individuals. The development of more patient-oriented information tools is needed to educate patients, to reduce physician influence on the decision-making process and to ensure that the patients’ decision reflects their own values and preferences.
doi_str_mv 10.1016/j.urolonc.2022.07.005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2702180006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1078143922002654</els_id><sourcerecordid>2702180006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c290t-8766eb640247126a0be51eed18de9bb1f75d82b171963141da7f84260e659083</originalsourceid><addsrcrecordid>eNqFkM9KxDAQh4soqKuPIOTopXUm2ybpSUT8Bwt6EK8hTaeYpW3WJF3w5mv4ej6JXda7p5nD7_sx82XZBUKBgOJqXUzB9360BQfOC5AFQHWQnaCSy5yXtTicd5Aqx3JZH2enMa4BsFSIJ9nbi0mOxhR_vr7ZhoKlTXJ-jMyPzNjktsTiFLbk-t6MlljnA0vvxFIgk4YZZL5jcTB9zwKNpmeDiZHiWXbUmT7S-d9cZK_3d6-3j_nq-eHp9maVW15DypUUghpRAi8lcmGgoQqJWlQt1U2DnaxaxRuUWIslltga2amSCyBR1aCWi-xyX7sJ_mOimPTgoqXdreSnqLkEjgoAxByt9lEbfIyBOr0JbjDhUyPonUa91n8a9U6jBqlnjTN3vedofmPrKOhoZ2GWWhfIJt1690_DL9Qtf7U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2702180006</pqid></control><display><type>article</type><title>Patients’ perceptions on active surveillance for the treatment of small renal masses</title><source>ScienceDirect Journals</source><creator>Charbonneau, Geneviève ; Hudon, Catherine ; Lavallée, Luke T. ; Kassouf, Wassim ; Gaboury, Isabelle ; Toren, Paul ; Couture, Félix ; Foley, Véronique ; Tétu, Amélie ; Richard, Patrick O.</creator><creatorcontrib>Charbonneau, Geneviève ; Hudon, Catherine ; Lavallée, Luke T. ; Kassouf, Wassim ; Gaboury, Isabelle ; Toren, Paul ; Couture, Félix ; Foley, Véronique ; Tétu, Amélie ; Richard, Patrick O.</creatorcontrib><description>•Several factors influence patients’ perceptions of active surveillance.•The physician's recommendation was reported as the most influencing factor.•The development of more patient-oriented information tools is needed.•Focus group discussion can be conducted virtually without any major outcome's impact. Most patients diagnosed with a small renal mass (SRM) are treated with definitive treatments such as surgery or thermal ablation. Given that some SRMs are benign or have low metastatic potential, active surveillance seeks to reduce the overtreatment and the potential complications. Active surveillance is an alternative that is being increasingly considered. Active surveillance has already been shown to be effective, but there is a current knowledge gap regarding patients’ perceptions of active surveillance and factors influencing their decision. To describe patients’ perceptions of active surveillance of SRMs and to identify factors influencing those perceptions. This multicenter descriptive qualitative study recruited patients diagnosed with a renal mass from three institutions, using purposeful sampling. Data were collected using focus group discussions, which were recorded and transcribed. A mixed thematic analysis was performed. Six focus group discussions were conducted with a total of 24 participants. Participants perceived active surveillance as an option to avoid definitive treatments and their potential risks. Active surveillance was, however, perceived to be a temporary solution that would affect their chance of survival and their quality of life. Seven factors were documented as influencing patients’ perceptions of active surveillance, the most important being their physician's recommendation. Perceptions of patients with SRMs toward active surveillance varies among individuals. The development of more patient-oriented information tools is needed to educate patients, to reduce physician influence on the decision-making process and to ensure that the patients’ decision reflects their own values and preferences.</description><identifier>ISSN: 1078-1439</identifier><identifier>EISSN: 1873-2496</identifier><identifier>DOI: 10.1016/j.urolonc.2022.07.005</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Active surveillance ; Focus group discussion ; Patients’ perceptions ; Qualitative descriptive study ; Renal cell carcinoma ; Small renal mass</subject><ispartof>Urologic oncology, 2022-11, Vol.40 (11), p.493.e17-493.e23</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c290t-8766eb640247126a0be51eed18de9bb1f75d82b171963141da7f84260e659083</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Charbonneau, Geneviève</creatorcontrib><creatorcontrib>Hudon, Catherine</creatorcontrib><creatorcontrib>Lavallée, Luke T.</creatorcontrib><creatorcontrib>Kassouf, Wassim</creatorcontrib><creatorcontrib>Gaboury, Isabelle</creatorcontrib><creatorcontrib>Toren, Paul</creatorcontrib><creatorcontrib>Couture, Félix</creatorcontrib><creatorcontrib>Foley, Véronique</creatorcontrib><creatorcontrib>Tétu, Amélie</creatorcontrib><creatorcontrib>Richard, Patrick O.</creatorcontrib><title>Patients’ perceptions on active surveillance for the treatment of small renal masses</title><title>Urologic oncology</title><description>•Several factors influence patients’ perceptions of active surveillance.•The physician's recommendation was reported as the most influencing factor.•The development of more patient-oriented information tools is needed.•Focus group discussion can be conducted virtually without any major outcome's impact. Most patients diagnosed with a small renal mass (SRM) are treated with definitive treatments such as surgery or thermal ablation. Given that some SRMs are benign or have low metastatic potential, active surveillance seeks to reduce the overtreatment and the potential complications. Active surveillance is an alternative that is being increasingly considered. Active surveillance has already been shown to be effective, but there is a current knowledge gap regarding patients’ perceptions of active surveillance and factors influencing their decision. To describe patients’ perceptions of active surveillance of SRMs and to identify factors influencing those perceptions. This multicenter descriptive qualitative study recruited patients diagnosed with a renal mass from three institutions, using purposeful sampling. Data were collected using focus group discussions, which were recorded and transcribed. A mixed thematic analysis was performed. Six focus group discussions were conducted with a total of 24 participants. Participants perceived active surveillance as an option to avoid definitive treatments and their potential risks. Active surveillance was, however, perceived to be a temporary solution that would affect their chance of survival and their quality of life. Seven factors were documented as influencing patients’ perceptions of active surveillance, the most important being their physician's recommendation. Perceptions of patients with SRMs toward active surveillance varies among individuals. The development of more patient-oriented information tools is needed to educate patients, to reduce physician influence on the decision-making process and to ensure that the patients’ decision reflects their own values and preferences.</description><subject>Active surveillance</subject><subject>Focus group discussion</subject><subject>Patients’ perceptions</subject><subject>Qualitative descriptive study</subject><subject>Renal cell carcinoma</subject><subject>Small renal mass</subject><issn>1078-1439</issn><issn>1873-2496</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkM9KxDAQh4soqKuPIOTopXUm2ybpSUT8Bwt6EK8hTaeYpW3WJF3w5mv4ej6JXda7p5nD7_sx82XZBUKBgOJqXUzB9360BQfOC5AFQHWQnaCSy5yXtTicd5Aqx3JZH2enMa4BsFSIJ9nbi0mOxhR_vr7ZhoKlTXJ-jMyPzNjktsTiFLbk-t6MlljnA0vvxFIgk4YZZL5jcTB9zwKNpmeDiZHiWXbUmT7S-d9cZK_3d6-3j_nq-eHp9maVW15DypUUghpRAi8lcmGgoQqJWlQt1U2DnaxaxRuUWIslltga2amSCyBR1aCWi-xyX7sJ_mOimPTgoqXdreSnqLkEjgoAxByt9lEbfIyBOr0JbjDhUyPonUa91n8a9U6jBqlnjTN3vedofmPrKOhoZ2GWWhfIJt1690_DL9Qtf7U</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Charbonneau, Geneviève</creator><creator>Hudon, Catherine</creator><creator>Lavallée, Luke T.</creator><creator>Kassouf, Wassim</creator><creator>Gaboury, Isabelle</creator><creator>Toren, Paul</creator><creator>Couture, Félix</creator><creator>Foley, Véronique</creator><creator>Tétu, Amélie</creator><creator>Richard, Patrick O.</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202211</creationdate><title>Patients’ perceptions on active surveillance for the treatment of small renal masses</title><author>Charbonneau, Geneviève ; Hudon, Catherine ; Lavallée, Luke T. ; Kassouf, Wassim ; Gaboury, Isabelle ; Toren, Paul ; Couture, Félix ; Foley, Véronique ; Tétu, Amélie ; Richard, Patrick O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c290t-8766eb640247126a0be51eed18de9bb1f75d82b171963141da7f84260e659083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Active surveillance</topic><topic>Focus group discussion</topic><topic>Patients’ perceptions</topic><topic>Qualitative descriptive study</topic><topic>Renal cell carcinoma</topic><topic>Small renal mass</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Charbonneau, Geneviève</creatorcontrib><creatorcontrib>Hudon, Catherine</creatorcontrib><creatorcontrib>Lavallée, Luke T.</creatorcontrib><creatorcontrib>Kassouf, Wassim</creatorcontrib><creatorcontrib>Gaboury, Isabelle</creatorcontrib><creatorcontrib>Toren, Paul</creatorcontrib><creatorcontrib>Couture, Félix</creatorcontrib><creatorcontrib>Foley, Véronique</creatorcontrib><creatorcontrib>Tétu, Amélie</creatorcontrib><creatorcontrib>Richard, Patrick O.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Charbonneau, Geneviève</au><au>Hudon, Catherine</au><au>Lavallée, Luke T.</au><au>Kassouf, Wassim</au><au>Gaboury, Isabelle</au><au>Toren, Paul</au><au>Couture, Félix</au><au>Foley, Véronique</au><au>Tétu, Amélie</au><au>Richard, Patrick O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patients’ perceptions on active surveillance for the treatment of small renal masses</atitle><jtitle>Urologic oncology</jtitle><date>2022-11</date><risdate>2022</risdate><volume>40</volume><issue>11</issue><spage>493.e17</spage><epage>493.e23</epage><pages>493.e17-493.e23</pages><issn>1078-1439</issn><eissn>1873-2496</eissn><abstract>•Several factors influence patients’ perceptions of active surveillance.•The physician's recommendation was reported as the most influencing factor.•The development of more patient-oriented information tools is needed.•Focus group discussion can be conducted virtually without any major outcome's impact. Most patients diagnosed with a small renal mass (SRM) are treated with definitive treatments such as surgery or thermal ablation. Given that some SRMs are benign or have low metastatic potential, active surveillance seeks to reduce the overtreatment and the potential complications. Active surveillance is an alternative that is being increasingly considered. Active surveillance has already been shown to be effective, but there is a current knowledge gap regarding patients’ perceptions of active surveillance and factors influencing their decision. To describe patients’ perceptions of active surveillance of SRMs and to identify factors influencing those perceptions. This multicenter descriptive qualitative study recruited patients diagnosed with a renal mass from three institutions, using purposeful sampling. Data were collected using focus group discussions, which were recorded and transcribed. A mixed thematic analysis was performed. Six focus group discussions were conducted with a total of 24 participants. Participants perceived active surveillance as an option to avoid definitive treatments and their potential risks. Active surveillance was, however, perceived to be a temporary solution that would affect their chance of survival and their quality of life. Seven factors were documented as influencing patients’ perceptions of active surveillance, the most important being their physician's recommendation. Perceptions of patients with SRMs toward active surveillance varies among individuals. The development of more patient-oriented information tools is needed to educate patients, to reduce physician influence on the decision-making process and to ensure that the patients’ decision reflects their own values and preferences.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.urolonc.2022.07.005</doi></addata></record>
fulltext fulltext
identifier ISSN: 1078-1439
ispartof Urologic oncology, 2022-11, Vol.40 (11), p.493.e17-493.e23
issn 1078-1439
1873-2496
language eng
recordid cdi_proquest_miscellaneous_2702180006
source ScienceDirect Journals
subjects Active surveillance
Focus group discussion
Patients’ perceptions
Qualitative descriptive study
Renal cell carcinoma
Small renal mass
title Patients’ perceptions on active surveillance for the treatment of small renal masses
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A47%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patients%E2%80%99%20perceptions%20on%20active%20surveillance%20for%20the%20treatment%20of%20small%20renal%20masses&rft.jtitle=Urologic%20oncology&rft.au=Charbonneau,%20Genevi%C3%A8ve&rft.date=2022-11&rft.volume=40&rft.issue=11&rft.spage=493.e17&rft.epage=493.e23&rft.pages=493.e17-493.e23&rft.issn=1078-1439&rft.eissn=1873-2496&rft_id=info:doi/10.1016/j.urolonc.2022.07.005&rft_dat=%3Cproquest_cross%3E2702180006%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c290t-8766eb640247126a0be51eed18de9bb1f75d82b171963141da7f84260e659083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2702180006&rft_id=info:pmid/&rfr_iscdi=true